Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Key benefits Why people compare it 1 FDA-approved as Egrifta for visceral adipose tissue reduction in lipodystrophy 2 15-18% VAT reduction demonstrated in two Phase 3 trials (N=816) 3 Improved triglycerides and waist circumference in key clinical data 4 Extended half-life (26-38 min) vs sermorelin due to trans-3-hexenoic acid modification 5 Improved verbal memory and executive function in older adults (Neurology study, p=0.03) 6 Physiological GH stimulation with intact pituitary negative feedback 7 Demonstrated 32% hepatic fat reduction in 12-month NAFLD trial 8 Well-characterized safety profile through FDA approval and post-marketing surveillance Deep research About Tesamorelin Tesamorelin is a synthetic analog of human growth hormone-releasing hormone (GHRH) consisting of all 44 amino acids of native GHRH with a trans-3-hexenoic acid moiety conjugated to the tyrosine residue at position 1 via a carbamate linker
Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL)
Providers may choose to customize a person's dose of compounded semaglutide for weight loss based on their medical history, side effects, or weight loss goals
No fillers are added
Healthcare providers should counsel patients about the distinction between compounded and FDA-approved products
US$ 26.91
US$ 21.68
US$ 21.48
US$ 22.58
